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Summary Estimated incidence rates are presented for three human immunodeficiency virus (HIV)-associated cancers [Kaposi's sarcoma
(KS), Burkitt's lymphoma (BL) and other non-Hodgkin's lymphomas (NHLs)] from across the African continent, based on data collected before
the HIV epidemic. Mapping of the rates and comparisons with a range of geographical variables indicate completely different distributions for
KS and BL but a degree of similarity in the occurrence of Burkitt's lymphoma and other NHLs. Comparisons with rates elsewhere in the world
suggest, most notably, that KS was as common in some regions of sub-Saharan Africa as was cancer of the colon in much of Western
Europe. Comparison with data from the era of AIDS indicates 20-fold increases in the occurrence of Kaposi's sarcoma in Uganda and
Zimbabwe. The highest rates for BL were three to four times the rates for leukaemia at young ages in Western populations, but the general
incidence of other NHL was no higher than in the West and very low rates were indicated for much of southern Africa.
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The risk of Kaposi's sarcoma (KS) and non-Hodgkin's lymphoma
(NHL), including Burkitt's lymphoma (BL), is increased in associ-
ation with human immunodeficiency virus (HIV) infection (Beral,
1991). All three malignancies have also been independently linked
to closely related herpesvirus infections: BL and other lymphomas
to the Epstein-Barr virus (Luxton et al, 1991) and KS to human
herpes virus 8 (HHV-8) (Chang et al, 1994).
The epidemiological features ofHIV-associated cancers inAfrica
may be affected by the fact that KS and BL were relatively common
there before the AIDS epidemic (Thijs, 1957; Oettle, 1962; Burkitt,
1962a; Taylor et al, 1972; Templeton, 1973; Hutt, 1984). To further
understand the aetiology ofthese conditions, and especially to gain
clues about the possible original geographical distribution ofHHV-
8, incidence rates ofKS and oflymphomas across Africa have been
estimated and mapped. The data consist of largely unpublished
information from a frequency survey supported by the British
Medical Research Council (MRC) and the International Agency for
Research on Cancer (IARC) during the 1960s and 1970s together
with material from published cancer series.
MATERIALS AND METHODS
Sources of cancer data
Incidence data have come from three main sources. A postal
survey ofcancer frequency, involving hospitals outside the capital
cities, was initiated by one of the authors (DB) in 1964 and
continued, with support from the MRC, for variable periods at
different centres until 1973. The survey was started in Uganda,
Kenya, Tanzania, Rwanda and Burundi with a monthly request to
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all hospitals for information onjust seven malignancies of partic-
ular local interest (Cook and Burkitt, 1971). However, about a
third of the hospitals were asked for details of all types of cancer
(the data used in the present study). In 1968, the survey was
expanded to cover all hospitals in Malawi and a few in the Sudan,
West Africa and southern Africa and, in the new areas, details of
all malignancies were requested from all participating centres. In
1968, also, a collaborative project supported by the Zambian
government was set up to request information from all hospitals in
Zambia, and datafrom these have been included here. Throughout
the survey, doctors were asked to record those malignancies that
were diagnosed on clinical grounds as well as those confirmed
histologically, thus avoiding theunderreporting oftumours atinac-
cessible sites that inevitably occurs in areas of limited medical
facilities (Burkitt et al, 1968).
Cancer registries were established in the major cities of Kenya
and Malawi, Tanzania and the Sudan with funding from the IARC,
and two Zambian registries were supported with local funding. In
each centre information was sought on all malignancies diagnosed
in the city hospital(s) (data used in the present survey) while
details were also recorded from the central histopathology labora-
tories for patients seen at other hospitals throughout each territory
(data used here only to supplement information fromhospitals that
were participating in the postal surveys). Histopathology laborato-
ries were mostly located in the major hospitals in the capital cities
(Kampala, Nairobi, Dar es Salaam and Lusaka), but in Zambia the
northern provinces were served by a laboratory in Kitwe and, in
Malawi, all specimens were sent via Blantyre to St Thomas's
Hospital in London. Data from the Malawi registry cover the
period 1968-72, those from Kenya and Zambia 1968-70, from
Tanzania 1969-71 and from the Sudan 1970-71. Data from the
Kampala CancerRegistry inUganda, supported by the then British
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energy and enthusiasm inspired cooperation over the years from medical centres all
over the continent.
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Empire Cancer Campaign (Cancer Research Campaign), were
separately available for the period 1964-68 and have also been
included. In the current analyses, patients who had been referred to
the central hospitals from elsewhere in the country were excluded
so as to avoid bias due to the more frequent referral of certain
types or sites of malignancy. For data from the Kampala Cancer
Registry information on referral was not available to us and only
patients from the districts ofeast and west Mengo, which flank the
city of Kampala, were included in the current database. In the esti-
mation of local incidence rates, account has been taken of the fact
that many patients who were resident in the major cities had previ-
ously come from distant regions to live and work there. To this
end, all patients have been allocated to a 'region of origin' (using
information on 'tribe' in East Africa, where this clan affiliation is
strongly regional, and on place of birth in Zambia and Malawi, if
available, or otherwise on place of residence except for patients
from the central hospitals in Zambia and Malawi stated to be resi-
dent in the central districts but having no place of birth informa-
tion. In addition, for persons attending hospital in the whole ofthe
western region (the Copperbelt) in Zambia only place ofbirth was
accepted as evidence of 'region oforigin'). Information on 'region
of origin' was available for 90% of patients. The remainder were
excluded from the analyses presented here.
Information on relative frequencies of cancer at other centres in
Africa has been taken from Cancer Incidence in Developing
Countries (Parkin, 1986) and also from earlier publications. The
numbers of tumours and the estimated cumulative rates for all
centres and series used, together with full references, are presented
in a separate appendix (available on request).
Estimation of incidence rates and adjustment for
underreporting
Given the scarcity of medical facilities in Africa, many areas are
not within easy reach of a hospital and so, except for a few urban
centres, a general underreporting of cancer is inevitable.
Knowledge of the relative stability of total (compared with indi-
vidual) cancer rates around the world, especially within continents
(Doll et al, 1966; 1970), together with indications ofmuch sharper
gradients of frequency for individual sites in Africa than are
common in the West (Cook and Burkitt, 1971), has been used to
establish a standard against which to adjust the observed incidence
rates for individual types of cancer. The basis of adjustment for
underreporting has been to assume that the level of incidence
everywhere in Africa was similar, for a core group of malignan-
cies, to the average rate for these pooled cancers in four centres
with particularly high standards of cancer registration that had
previously published incidence rates: Johannesburg and Natal in
South Africa (Higginson and Oettle, 1960; Schonland and
Bradshaw, 1968); Ibadan, Nigeria (Edington, 1970); and Kampala,
Uganda (Davies et al, 1962), though using the 1964-68 data for
Kampala rather than the earlier published series. The average rates
for the four centres used as standard are referred to as the '4-
registry' rates.
The core group of malignancies for which the assumption of
equal incidence has been made consists of all malignancies other
than those that showed considerable geographical variation within
Africa (from common or relatively common to almost non-
existent within short distances); the latter comprise cancers of the
oesophagus, lung, penis, bladder, nasopharynx and BL. Cancers of
the cervix and breast have also been omitted from the total
Table 1 Geographical association of male and female estimated cumulative
incidence rates
Malignancy Correlation coefficient (R)
Kaposi's sarcoma 0.20a
Burkitt's lymphoma 0.68d
Non-Burkitt's lymphoma 0.50d
Hodgkin's lymphoma 0.61d
Non-Hodgkin's lymphoma 0.37d
ap< 0.10. dp< 0.001.
Table 2 Correlation coefficients between different environmental factors
MOIS POPN ALT RAIN SOIL REM LAT
Moisture index (MOIS) 1.00 0.06 0.17 0.51d 0.40d -0.15 -0.31c
Population density (POPN) 1.00 -0.02 0.09 -0.03 0.45d 0.05
Altitude (ALT) 1.00 -0.15 0.30C 0.12 -0.22b
Rainfall (RAIN) 1.00 0.45d 0.17 0.49d
Volcanic ferrisols (SOIL)d 1.00 -0.14 0.37d
Remoteness (REM) 1.00 0.25b
Latitude (LAT) 1.00
bp< 0.05. cp < 0.01. dp < 0.001. Estimated near each centre as the
approximate percentage area of ferrisols (mostly on basic volcanic rocks)
plus one-quarter of the approximate percentage of associated ferralitic soils
(mostly on non-volcanic rocks and often occurring widely in ferrisol-rich
regions).
because, although they show less marked geographical variation
and there are no areas where either is very rare, whichever of the
two predominates locally tends to be by far the most common
cancer diagnosed in women. Relatively slight variations in inci-
dence would, therefore, be reflected in the pooled incidence of the
core malignancies. The core group of malignancies derived by
excluding these sites is referred to subsequently as the 'less vari-
able' (LV) tumours.
Age-standardized incidence ratios (SIRs) were calculated for
each local area using expected values derived from application of
standard age-specific rates to local populations. Relatively good
census data, with an age breakdown, became available during the
course of the East and Central African cancer surveys for most of
the territories involved and for these it has been possible to use
local population data. Overall, the data suggest a broad similarity
of age structure common to rural areas in Africa and another
pattern for cities. In the latter there is an excess of young adults,
particularly of young men, who have come to town to seek work.
With this knowledge, when detailed local population data were not
available for areas outside East and Central Africa, estimates of
age structure were taken either from average 'urban', 'rural' or
combined 'urban/rural' population structures, as appropriate, or
from similar neighbouring areas. The method used for adjusting
for underreporting requires an estimation only of the age structure
ofpopulations not their total size.
The SIRs for individual malignancies were multiplied by the
'standard' cumulative rates for each type of cancer (age 0-64
years) (Day, 1976) to convert them to rates. The age group 0-64
years was chosen in view of the young age structure of African
populations and of the underuse of medical facilities by elderly
patients. The expected and observed values used were for persons
ofall ages, but the majority ofpatients were below age 65 in series
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Table 3 Relative risks of Kaposi's sarcoma and lymphomas associated with different geographical variables in sub-Saharan Africa
Relative risks P-values for
Heterogeneity Trend
Moisture index
Kaposi's sarcoma
Burkitt's lymphoma
Non-Burkitt's lymphoma
NHL
Hodgkin's lymphoma
Population density
Kaposi's sarcoma
Burkitt's lymphoma
Non-Burkitt's lymphoma
NHL
Hodgkin's lymphoma
Altitude (in feet)
Kaposi's sarcoma
Burkitt's lymphoma
Non-Burkitt's lymphoma
NHL
Hodgkin's lymphoma
Rainfall (in mm)
Kaposi's sarcoma
Burkitt's lymphoma
Non-Burkitt's lymphoma
NHL
Hodgkin's lymphoma
Volcanic ferrisols (% area)
Kaposi's sarcoma
Burkitt's lymphoma
non-Burkitt's lymphoma
NHL
Hodgkin's lymphoma
Remoteness/westernization
(Wn)
Kaposi's sarcoma
Burkitt's lymphoma
non-Burkitt's lymphoma
Lymphosarcoma
Hodgkin's lymphoma
Latitude
Kaposi's sarcoma
Burkitt's lymphoma
Non-Burkitt's lymphomas
NHL
Hodgkin's lymphoma
Total observed tumours
Kaposi's sarcoma
Burkitt's lymphoma
Dry
1.00
1.00
1.00
1.00
1.00
Low
1.00
1.00
1.00
1.00
1.00
< 2000
1.00
1.00
1.00
1.00
1.00
< 1000
1.00
1.00
1.00
1.00
1.00
< 15%
1.00
1.00
1.00
1.00
1.00
Remote
1.00
1.00
1.00
1.00
1.00
0-50N/S
1.00
1.00
1.00
1.00
1.00
Moderately dry
1.69
3.47
1.48
1.34
1.91
Moderate
1.37
1.74
1.14
1.09
1.24
2000-
2.94
0.95
1.03
1.1
0.79
1000-
1.62
2.31
1.66
1.55
2.07
15%-
1.8
1.04
1.11
0.98
1.73
Moderate
0.84
0.64
0.87
0.81
1.13
5-15oS
0.56
1.01
1.02
0.99
1.19
1074 Non-Burkitt's lymphomas
955 NHL
Hodgkin's lymphoma
Moderately humid
1.85
1.45
1.25
1.21
1.39
High
1.4
1.17
1.23
1.15
1.46
4000-
2.22
1.02
1.03
1
1.04
1400-
2.17
1.51
1.61
1.77
1.22
35%-
2.23
0.99
1.15
1.07
1.53
Agriculture
Wn
0.62
0.52
0.89
0.79
1.3
15-25oS
0.44
0.32
0.69
0.69
0.7
2273
690
583
aThe column headings used for the moisture index are abbreviations for combinations of mapped categories (Grove et al, 1967) as follows: 'dry' - 'arid',
'semiarid' and 'semiarid/dry subhumid'; 'moderately dry' - 'dry subhumid' and 'dry subhumid/moist subhumid'; 'moderately humid' - 'moist subhumid' and 'moist
subhumid/humid'; 'humid' - 'humid' and 'very humid'.
where the age of patients was known and so linking the SIRs to
0-64 cumulative rates gives the most appropriate comparison with
rates from outside Africa. For malignancies other than those of
particular interest in the present paper, expected values were
derived using the '4-registry' age-specific rates. BL was not classi-
fied separately from other NHL in the Ibadan data, or KS from
other connective tissue tumours in any of the centres except
Kampala. Average East African age-specific rates (adjusted for
underreporting by reference to the '4-registry' LV rates) derived
from the MRC frequency study were, therefore, used as standard
for KS and BL, and average '4-registry' rates excluding Ibadan
were used as standard for other NHL. The conversion of the SIRs
to estimated rates centred on the 'standard' cumulative rate means
that the use of different 'standards' for different malignancies will
have little effect on the final estimates. The adjustment for under-
reporting of the estimated rates was made by multiplying the local
rates for individual sites by the '4-registry' rate for the LV tumours
divided by the local LV tumours rate.
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Humid
2.33
1.34
1.59
1.67
1.31
Urban
0.37
0.95
1.09
1.05
1.2
5000+
2.53
0.19
0.82
0.78
0.83
1800+
1.51
1.68
1.8
1.97
1.47
55%+
3.11
0.48
1.15
1.17
1.12
Tourist/industrial
Wn
0.34
0.59
0.8
0.77
0.95
250S
0.31
0.22
0.32
0.28
0.47
0.02
0.005
0.07
0.042
0.31
<0.001
0.27
0.68
0.87
0.77
<0.001
<0.001
0.57
0.32
0.79
0.007
0.14
<0.001
<0.001
0.04
<0.001
0.35
0.85
0.7
0.19
< 0.001
0.37
0.7
0.42
0.81
< 0.001
< 0.001
< 0.001
< 0.001
0.06
0.007
0.05
0.12
0.02
0.79
0.005
0.68
0.51
0.7
0.5
0.003
0.04
0.42
0.25
0.86
0.02
0.58
0.003
< 0.001
0.76
< 0.001
0.16
0.44
0.27
0.85
< 0.001
0.14
0.3
0.14
0.8
< 0.001
< 0.001
< 0.001
< 0.001
0.08
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A few ofthe published frequency series that have been incorpo-
rated in the study comprised only malignancies diagnosed at a
central histopathology laboratory and occasionally, in regional
breakdowns of the data, only details of selected sites. For these
series, knowledge gained from the experience of cancer registra-
tion within East and Central Africa, with regard to the frequency
ofreferral to central hospitals for different sites ofmalignancy and
the frequency with which biopsies are taken from different sites,
was used to provide additional adjustment to allow for site-
specific underreporting by changing the balance of accessible and
inaccessible tumours in the total.
Incomplete regional data have been used in the present study,
for example from Cameroon and Zaire, only where numbers have
been given both for the specific tumours (KS) and for the total
number of all malignancies. In these instances, a profile of 'less
variable' tumours was built up from knowledge of the relative
frequency of individual sites in national data or in neighbouring
territories. In a few instances, the number of KS or BL tumours,
categorized as connective tissue or NHL in the published series,
was estimated from comments in the literature. In adjusting for
underreporting, an exceptionally high frequency at a site included
in the LV tumours was adjusted downward to an average level, as,
for example, with liver cancer in Maputo, which would otherwise
have accounted for two-thirds of the LV total. (Details of all local
adjustments are given in the notes accompanying Appendix Table
1 while the rates appear on the maps with a qualifying 'e'.)
Sensitivity analyses were carried out to establish the likely
limits of error inherent in the estimations of incidence, given that
the rates for the LV tumours may themselves have been subject to
some underreporting or been less homogeneous than anticipated.
Estimates ofincidence were recalculated with the LV age-specific
and cumulative rates (used as standard) set equal to the highest of
the '4-registry' rates, those observed in Natal, rather than to the
average values, and, alternatively, to the rates for the same period
in a black population living outside Africa, in Jamaica (Brooks,
1976). In addition the effect ofexcluding KS and NHL themselves
from the LV tumours was also considered.
Mapping of estimated incidence rates
Maps were prepared in which estimated cumulative rates (per
1000 population at risk) were plotted on the local areas to which
they refer. The male rates forKS, BL and NHL and the female rate
for KS are shown in Figures 1. Correlation coefficients for the
association between male and female rates for the different
lymphomas show a similar pattern ofoccurrence (Table 1).
Associations of incidence with geographical
parameters
For sub-Saharan Africa, relative risks associated with a number of
geographical variables were derived by logistic regression so as to
characterize the areas ofhigh and low incidence for the malignan-
cies of interest. The variables [moisture index, a combination of
rainfall and evaporation (Grove, 1967); population density; alti-
tude; rainfall; occurrence of ferrisols, a soil type that has been
suggested as a risk factor for KS (Zieglar, 1994); remoteness, i.e.
from industrialization andwesternization; and latitude] were either
read from maps or derived from geographical knowledge of the
different areas during the relevant time period (Lewis et al, 1967;
Harrison Church et al, 1967).
The logistic regressions (Glim, 1987) were carried out using the
summed male and female observed values for the malignancies of
interest as the dependent variable and offsetting the logarithm of
the expected values (adjusted for underreporting). Use of the
pooled male and female data allowed a finer areal subdivision in
some regions than was used for the purposes of mapping, when
sex-specific rates were used so as to permit international compar-
isons. There is a considerable degree of correlation between the
environmental and social variables included in the logistic regres-
sion analyses (coefficients are given in Table 2). However, in view
of the approximate nature of such geographical comparisons,
lacking as they do information on the exposure levels ofindividual
patients, no attempt was made to apportion risk more specifically
in multifactorial analyses.
RESULTS AND DISCUSSION
Kaposi's sarcoma
The highest rates of more than 6 per 1000 were found in a broad
strip across equatorial Africa, with particularly high rates in north-
eastern Zaire and in western Uganda and Tanzania (Figure lA). In
addition, narrow belts of high incidence stretched westward from
eastern Zaire to the coast in Cameroon and southward down the
Rift Valley into Malawi. Assumption ofa level ofincidence forthe
LV tumours as high as the level ofincidence in Natal, or exclusion
of KS and NHL from the LV tumours, raises the incidence of the
highest estimated rates from 1 to 2 per 1000. Setting the level of
the LV tumours equal to the rates observed in Jamaica gives
increases up to 3 per 1000, giving a probable maximum cumula-
tive incidence of c. 15 per 1000. By comparison, calculation of
cumulative rates from European data (Cottoni et al, 1996; Grulich
et al, 1992), suggest a highest male incidence of 0.8 per 1000 for
Sardinia and a rate of only 0.05 per 1000 for England and Wales.
The estimated cumulative rates for KS in western Uganda and
eastern Zaire were on a par with those for cancer of the colon in
much of Western Europe (one of the commoner Western malig-
nancies) (Muir et al, 1987).
KS in Africa was about eight to ten times more common in men
than in women. The rates forthe two sexes were less closely corre-
lated than the rates for the lymphomas (Table 1). However, the
broad zone within which rates were elevated above those observed
elsewhere in the world was similar to that for males (Figure lB).
The relative risks associated with the geographic variables
(Table 3) characterize the areas within which KS was common,
with the highest levels near the equator; in areas with an altitude
over 2000 ft; in areas with moderate to high humidity; in areas that
are mostly rural and remote from westernization (although densely
populated); and in areas that are likely to have ferrisol and
ferralitic soils. Significant trends were observed for all these vari-
ables. The conditions outlined are typical of the high-incidence
areas in the volcanic mountains that fringe the western branch of
the great Rift Valley in eastern Zaire, in western Uganda and
Tanzania, and further south in Malawi. Volcanic mountains also
occur on the west of the continent in the mountainous areas of
Cameroon where the incidence again appears to be elevated.
However, there is some indication that, in this respect, there were
anomalously low rates in Rwanda and Burundi on the watershed
between Zaire and Uganda and Tanzania (Figure 1A and
Appendix Table 1). In central Kenya, the physical conditions are
similar to those of the Rift Valley in Uganda and Zaire, although
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Figure 1 Estimated cumulative incidence rates per 1000 (age 0-64). (A) Kaposi's sarcoma, males. (B) Kaposi's sarcoma, females. (C) Burkitt's lymphoma,
males. (D) Non-Hodgkin's, non-Burkitt's lymphoma, males. 2e= centres where the estimates of cumulative incidence rest on specific assumptions, outlined in
the text, and described in full in the notes accompanying Appendix Table 1. Centres where a zero rate is based on no cases or represents a rate of < 0.05 are
shown as 'o' instead of '0' in B. Rates from series with LV tumours < 100 are shown in smaller typeface
the incidence is only moderate. However, in the extensive volcanic
mountains of Ethiopia, which are as remote as those of eastern
Zaire and south-west Uganda, are almost as densely populated and
have widespread areas offerrisols, there were indications ofonly a
low incidence of KS (Burkitt, 1966; Lester and Tsega, 1976).
The broad range ofaltitude, and thus temperatures, at which the
incidence is elevated, and the broad range of moisture zones (in
contrast to the pattern for BL), do not indicate clear climatic limits
on the occurrence of the disease in agreement with a previous
study (Taylor et al, 1972). A recent study from Italy found a higher
risk for classic (pre-AIDS) KS in persons born in areas where
malaria is endemic (Geddes et al, 1995). In Africa, however, many
ofthe highest estimated rates occur in areas ofhigh altitude where
malaria is almost unknown.
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Recent publications of cancer incidence in Africa suggest
dramatic increases in the incidence of KS over the last 10-15 years
(Wabinga et al, 1993; Basset et al, 1995; Newton et al, 1996),
presumably as a result of the HIV epidemic. Adjustment for under-
reporting among the recent data for males from Butare, Kampala
and Harare suggests incidence rates that by 1990 had almost
doubled in Rwanda, to over 5 per 1000, and had increased around
20-fold in Uganda and Zimbabwe, to over 55 per 1000 in Kampala
and to around 22 per 1000 in Harare (Appendix Table I). The rather
modest rate in Rwanda following the start of the HIV epidemic is
consistent with the low rates in the 1960s described above for
Rwanda and Burundi and also with the relatively low seropreva-
lence rates of HIV reported from much of Rwanda, around 10% in
towns such as Butare (Rwanda HIV Study Group, 1989) compared
with 40% in parts of Kampala (Ugandan Ministry of Health, 1997).
The recently discovered HHV-8 is now considered by many to
correlate geographically in its occurrence with the occurrence of KS
and not to be generally ubiquitous in human populations (Gao et al,
1996). If this is true, then the pattern of incidence shown here
(Figure IA) may possibly mirror the distribution ofthe virus prior to
the advent of AIDS. This suggests that there may have been a
previous spread of infection from an original focus in high-altitude
north-eastern Zaire, perhaps following routes of trade or of migra-
tion in search of work. Temporary migration of workers from
Zambia and Malawi both to the copper mines in Katanga, Zaire and
to the gold mines in South Africa could explain the occurrence of
KS as far south as the northern Transvaal and the south of
Mozambique. Similarly, the annual pilgrimage to Mecca from the
Muslim north of West Africa and even trade between the old inland
kingdoms of West Africa and southern Europe may have
contributed to the spread of the disease to Mediterranean countries,
where it was more common than in non-Mediterranean Europe prior
to the advent of AIDS (Qunibi et al, 1988; Geddes et al, 1994).
Burkitt's lymphoma
The map of BL (Figure 1C) shows, in terms of incidence, the
pattern of frequency that has previously been described in great
detail for this malignancy (Burkitt, 1962a,b, 1963, 1964). The
highest incidence rates are estimated at between 4 and 5 per 1000
in the West Nile district of Uganda and in the Mara, Mwanza and
Shinyanga districts of Tanzania. Most cases occurred in those
under the age of 20 and the rates compared with an incidence of
only 0.8 per 1000 for leukaemia among young males in the UK
(Waterhouse et al, 1976).
The estimated cumulative incidence of BL has increased in
Kampala, Uganda, between 1964-68 and 1989-93, from 0.2 to 0.8
per 1000 for males and from 0.04 to 0.5 per 1000 for females (an
average sevenfold increase for both sexes combined, P < 0.001).
All the recent cases occurred in children (Wabinga et al, 1993),
and there is thus no sign of an increase in young adults such as has
occurred in the West in association with HIV. However, it is not
known whether the children with BL were HIV positive. There is
no sign of an increase in BL at the other centres, Butare and
Harare, for which recent data are available (Appendix Table 1).
The areas ofparticularly high incidence have been defined as areas
where malaria is hyperendemic (Burkitt, 1969), and the present study
gives no evidence that does not support the possible relationship with
malaria. The declining relative risks with increasing westernization
(Table 3) include areas such as Kinshasa and Kampala where effec-
tive malaria eradication was thought to have limited the disease
despite conditions that were suited to its occurrence (Burkitt, 1969).
The same explanation has been also given for the very low frequency
ofthe disease noted in the island ofZanzibar (Chopra, 1968). It is not
known whether the increase in BL apparent in 1989-91 in Kampala
follows an increase in the frequency of malaria.
Non-Hodgkin's lymphoma, excluding Burkitt's
lymphoma
Features of note in the map of NHL (Figure 1D) are a relatively
low incidence throughout southern Africa with rates mostly of 1
per 1000; a broad belt of elevated incidence throughout tropical
Africa (from Malawi, Zambia and Angola in the south to Senegal
and the Sudan in the north) with rates in the range 2-4 per 1000
over most of central and East Africa; and (in contrast to the maps
for KS and BL) relatively high rates of 4 and 5 per 1000 in North
Africa. In the island of Madagascar the rate was similar to that of
central rather than southern Africa. There were certain small
centres in the tropical belt where very few lymphoid tumours were
diagnosed, and these are of suspect validity.
The only geographical variables (apart from latitude) to show an
association with the occurrence of NHL were rainfall and the related
'moisture index' (Table 3). The relative risks showed a clear trend of
incidence from areas with an annual rainfall ofless than 1000 mm to
those with more than 1800 mm. There was no indication of a
gradient with altitude that might suggest an effect of temperature or
the influence of ultraviolet radiation (Adami et al, 1995).
Analysis of 1967-73 data from Uganda showed a geographical
association for the occurrence of BL and other NHL (especially
high-grade lymphomas) Schmauz et al, 1990). Calculation of corre-
lation coefficients for the sub-Saharan areas shown on the maps
(excluding the areas of suspiciously low lymphoma rates mentioned
above) confirms this association over a much broader area (rs 0.455,
P < 0.001). The coefficients for KS and BL or KS and other NHL
were both non-significant (0.104 (P> 1.0) and 0.224 (P = 0.1).
Comparison ofrates for NHL in Africa with rates typical forother
continents during similar periods (using data from Doll et al, 1966,
1977; Waterhouse et al, 1976) shows a mid-range cumulative
incidence (age 0-64 years) around Kampala and in Dakar (Senegal)
very similar to that in Birmingham, UK. In contrast, the rates from
southern Africa (for Bulawayo, Natal and Johannesburg) are very
low - lower even than those reported from India and Japan. The
rates for the black population of San Francisco were intermediate
between the Senegal/Uganda rates and the high (pre-AIDS) rates for
the white population of San Francisco. Assumption of a general
cancer incidence in Africa as high as in Natal or Jamaica, or exclu-
sion of KS and BL from the LV tumours, would raise the estimated
rates for Kampala and Dakar to around 4 per 1000 and put them on
a par with those for the black population ofSan Francisco.
The relatively high rates for other NHL in North Africa partly
reflect the high incidence of intestinal lymphomas associated with
malabsorption syndrome that occurs to the south of the
Mediterranean and in the Middle East. In sub-Saharan Africa,
study of 44 gastrointestinal lymphomas diagnosed in Uganda
between 1964 and 1975 found no indication of associated malab-
sorption syndrome (Owor et al, 1977).
There has been no significant increase in the incidence of NHL
at any ofthe three centres (Butare, Kampala and Harare) for which
recent data are available.
It is possible that there has been some confusion in the diag-
noses of Hodgkin's and NHL, particularly in areas where medical
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facilities are scarce. Even so, the combination of the two diseases
would made little difference to the pattern ofdistribution for NHL
since the estimated cumulative incidence for Hodgkin's lymphoma
is similar throughout Africa, at around 1 per 1000 (Appendix Table
1 and Appendix Figure 4).
CONCLUSIONS
Data have been presented for three types of cancer (KS, BL and
NHL) which, in the West, have a raised incidence in association
with HIV infection. All three were known or thought to have a
relatively high frequency in tropical Africa but, for the first time,
rates have been estimated across the continent that permit compar-
ison with incidence rates elsewhere in the world and which give a
more accurate picture of former levels of incidence within Africa
than has previously been available. The maps and the comparisons
with geographical variables emphasize the completely different
distribution of KS and BL within the zone where they are both
common and highlight the exceptionally high incidence of KS and
BL there (prior to the start of the HIV epidemic) compared with
the rest ofthe world. Other NHL shows some degree ofassociation
with the distribution of BL but appears to have occurred less
frequently in central Africa than in many Western countries,
whereas the rates for southern Africa were low.
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